Predicting Long-Term Effects of Ranibizumab Therapy on the Diabetic Retinopathy Severity Score (DRSS) based on the Short-Term DRSS Improvement in the Ranibizumab for Edema of the Macula in Diabetes – Protocol 3 with High Dose (READ-3) Study
2019
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI